Serum Markers of Iron Metabolism in Chronic Liver Diseases
DOI:
https://doi.org/10.3889/oamjms.2018.251Keywords:
Steatosis, Serum ferritin, Serum iron, Transferrin saturation, Chronic liver diseaseAbstract
BACKGROUND: Disorders in the metabolism of iron in the direction of iron overload are observed not only in primary hemochromatosis but also in some chronic liver diseases other aetiology. Elevation of serum iron, ferritin and transferrin saturation is reported in nonalcoholic fatty liver disease and alcohol, chronic hepatitis C and liver cirrhosis.
AIM: Aim of the study was to evaluate and compare the frequency of the iron serum markers in patients with various chronic liver diseases.
MATERIAL AND METHODS: The study included a total of 246 persons -186 patients with chronic liver disease without cirrhosis (-115 men, women -71; average age of 50.41 ± 12.85, from 23 to 77 years) and 60 healthy controls (-30 men, women -30, middle-aged 50.50 ± 11.31, from 29 to 83 years). Medical history, physical examination and demographic data including height, weight, laboratory and instrumental studies were performed.
RESULTS: The highest incidence of elevated serum iron, transferrin saturation and ferritin and decreased serum hepcidin found in cases of alcoholic liver disease (ALD), nonalcoholic fatty liver disease (NAFLD) and chronic hepatitis C (CHC).
CONCLUSION: Finally, analysis of the changes in serum markers of iron metabolism shows that the difference between healthy and sick with liver disease is primarily due to changes in alcoholic and nonalcoholic fatty liver disease, particularly steatohepatitis, and chronic hepatitis C.Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Day CP, James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology 1998; 11:842-5. https://doi.org/10.1016/S0016-5085(98)70599-2
Deguti MM, Sipahi AM, Gayotto LC et al. Lack of evidence for the pathogenic role of iron and HFE gene mutations in Brazilian patients with nonalcoholic steatohepatitis. Braz J Med Biol Res. 2003; 36:739-45. https://doi.org/10.1590/S0100-879X2003000600009 PMid:12792703
Deugnier Y, Brissot P, Loréal O. Iron and the liver: update 2008. J Hepatol. 2008; 48(Suppl 1): S113-23. https://doi.org/10.1016/j.jhep.2008.01.014 PMid:18304682
Deugnier Y, Turlin B. Pathology of hepatic iron overload. World J Gastroenterol. 2007; 13:4755 -4760. https://doi.org/10.3748/wjg.v13.i35.4755 PMid:17729397 PMCid:PMC4611197
Di Bisceglie AM, Bonkovsky HL, et al. Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trial. Hepatology. 2000; 32: 135-138. https://doi.org/10.1053/jhep.2000.8700 PMid:10869301
Dostalikova-Cimburova M, Kratka K, Stransky J, et al. Iron overload and HFE gene mutations in Czech patients with chronic liver diseases. Dis Markers. 2012; 32(1):65-72. https://doi.org/10.1155/2012/790464 PMid:22297603 PMCid:PMC3826488
Duseja A, Das A, Das R et al. The clinicopathological profile of Indian patients with nonalcoholic fatty liver disease (NAFLD) is different from that in the West. Dig Dis Sci. 2007; 52:2368-74. https://doi.org/10.1007/s10620-006-9136-y PMid:17420951
Ekstedt M, Franzen LE, Mathiesen UL, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. 2006; 44: 865-73. https://doi.org/10.1002/hep.21327 PMid:17006923
Fernandez-Real JM, Lopez-Bermejo A, Ricart W. Cross-talk between iron metabolism and diabetes. Diabetes. 2002; 51:2348-54. https://doi.org/10.2337/diabetes.51.8.2348 PMid:12145144
Fracanzani AL, Conte D, Fraquelli M, et al. Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease. Hepatology. 2001; 33: 647-51. https://doi.org/10.1053/jhep.2001.22506 PMid:11230745
Fujita N, Miyachi H, Tanaka H, et al. Iron overload is associated with hepatic oxidative Damage to DNA in nonalcoholic steatohepatitis. Cancer Epidemiol Biomarkers Prev. 2009; 18:424-32. https://doi.org/10.1158/1055-9965.EPI-08-0725 PMid:19190144
Harrison-Findik DD, Schafer D, E Klein, et al. Alcohol metabolism -mediated oxidative stress downregulates hepcidin transcription and leads to increased duodenal iron transporter expression. J Biol Chem. 2006; 281:22974-82. https://doi.org/10.1074/jbc.M602098200 PMid:16737972
Ioannou GN, Dominitz JA, Weiss NS, et al. Racial differences in the relationship between hepatitis C infection and iron stores. Hepatology. 2003; 37: 795-801. https://doi.org/10.1053/jhep.2003.50147 PMid:12668972
Kemna EH, Kartikasari AE, van Tits LJ, et al. Regulation of hepcidin: Insights from biochemical analyses on human serum samples. Blood Cells Mol Dis. 2008; 40:339-346. https://doi.org/10.1016/j.bcmd.2007.10.002 PMid:18023212
Kohgo Y, Ohtake T, Ikuta K, Suzuki Y, Torimoto Y, Kato J. Dysregulation of systemic iron metabolism in alcoholic liver diseases. J Gastroenterol Hepatol. 2008; 23(Suppl 1): S78-81. https://doi.org/10.1111/j.1440-1746.2007.05290.x PMid:18336670
Krastev Z. Liver damage score-a new index for evaluation of the severity of chronic liver diseases. Hepatogastroenterology. 1998; 45(19):160-9. PMid:9496507
Nelson JE, Bhattacharya R, Lindor KD et al. HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis. Hepatology. 2007; 46: 723-9. https://doi.org/10.1002/hep.21742 PMid:17680648
Nelson JE, Wilson L, Brunt EM, Yeh MM, et al. Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease. Hepatology. 2011; 53(2):448-57. https://doi.org/10.1002/hep.24038 PMid:21274866 PMCid:PMC3058264
Olynyk JK, Reddy KR, Di Bisceglie AM, et al. Hepatic iron concentration as a predictor of response to interferon-alfa therapy in chronic hepatitis C. Gastroenterology. 1995; 108:1104-9. https://doi.org/10.1016/0016-5085(95)90209-0
Price L, Kowdley KV. The role of iron in the pathophysiology and treatment of chronic hepatitis C. Can J Gastroenterol. 2009; 23(12):822-8. https://doi.org/10.1155/2009/290383 PMid:20011735 PMCid:PMC2805519
Recalcati S, Invernizzi P, Arosio P, et al. New functions for an iron storage protein: the role of ferritin in immunity and autoimmunity. J Autoimmun. 2008; 30: 84-9. https://doi.org/10.1016/j.jaut.2007.11.003 PMid:18191543
Downloads
Published
How to Cite
Issue
Section
License
http://creativecommons.org/licenses/by-nc/4.0
